Take MAP & be a Healthy Champion!

    Clinical studies results1-5,8-10,16,37,38 have shown that the use of the original MAP Master Amino Acid Pattern®, during physical activity:
    • Provides a faster and better muscle mass growth, muscle strength and muscle endurance;
    • Provides a faster and better muscle recovery after physical activity; and
    • Provides a faster, lighter and easier digestion;
    in comparison to any dietary protein, protein or amino acid supplement.

    Take MAP & go the extra mile!

    What is MAP Master Amino Acid Pattern®?

    MAP Master Amino Acid Pattern® is the unparalleled, unique amino acid formula discovered by the International Nutrition Research Center, a leading American research institution in the field of human nutrition lead by Prof. Dr. Maurizio Luca Moretti®. In recognition of MAP Master Amino Acid Pattern®’s originality and unprecedented nutritional effectiveness, patents have been granted by the United States, the European Union, Canada and Japan.

    Since 1992, the results of forty-six scientific clinical studies1-46, performed in human subjects, have shown that MAP Master Amino Acid Pattern® can substitute dietary proteins in a safer and nutritionally more effective way. The previous mentioned clinical studies results have also shown the use of MAP Master Amino Acid Pattern® to be: (a) the most nutritious; (b) the safest; (c) the one that provides the lowest amount of calories; and (d) the one that can provide a faster, lighter and easier digestion in comparison to any dietary protein, protein supplement or amino acid supplement.


    Take MAP & the sky is the limit!

    Why is MAP Master Amino Acid Pattern® the most nutritious in comparison to any dietary protein, protein or amino acid supplement?

    Because comparative, double-blind, triple and quintuple crossover clinical studies results1-5,8-10 have shown that MAP Master Amino Acid Pattern® provides an unprecedented 99% Net Nitrogen Utilization® (NNU®). This means that 99% of MAP Master Amino Acid Pattern®’s constituent amino acids act as “building blocks”, namely as precursor of Body Proteins Synthesis (BPS), thus becoming body’s constituent proteins.

    By comparison, (a) an average of 32% of the constituent amino acids of dietary proteins, from animal origin, can act as “building blocks”; in contrast (b) only an average of 16% of the constituent amino acids of dietary proteins, from vegetable origin, can act as “building blocks”; as well as (c) also an average of 16% of the constituent amino acids of protein supplements, from either animal or vegetable origin, can act as “building blocks” because their main protein sources are whey, casein or soy; on the contrary, (d) only 0% of the constituent amino acids of any amino acid supplement containing less than eight essential amino acids, such as branched-chain amino acids supplements, can act as “building blocks”; on the other hand, (e) an average of 16% of the constituent amino acids of amino acid supplements containing no less than eight essential amino acids, such as amino acids derived from hydrolyzed dietary proteins of whey, casein or soy, can act as “building blocks”. As a result, MAP Master Amino Acid Pattern® can provide approx. 3 to 6 times more “building blocks”, namely Body Protein Synthesis (BPS), in comparison to any high biological value dietary protein, protein or amino acid supplement. Furthermore, the previously mentioned clinical studies results1-5,8-10 have shown that each human subject could maintain his body’s Nitrogen Balance in equilibrium by taking MAP Master Amino Acid Pattern®, in total substitution of dietary proteins, in a dosage of only 400 mg/kg*/day, providing an equivalent of less than 2 kcal/day (1 g of MAP™ = 0.04 kcal) (*Ideal weight). This means that 1 g (1 tablet) of MAP Master Amino Acid Pattern® provides a Body Protein Synthesis (BPS) equivalent to that provided by at least 2.5 g of any high biological value dietary protein, requiring, however, a digestion time 6 to 12 times shorter than the one required by dietary proteins. These facts confirm why MAP Master Amino Acid Pattern® is the most nutritious in comparison to any dietary protein, protein  or amino acid supplement.


    Why is the use of MAP Master Amino Acid Pattern® the safest in comparison to any dietary protein, protein or amino acid supplement?

    Because scientific clinical studies results1-5,8-10 have shown that MAP Master Amino Acid Pattern®, after its absorption, releases only 1% of Nitrogen Catabolites, namely metabolic toxic waste that must be catabolized through the liver and kidney functions before it is eliminated through the urine.

    By comparison, (a) dietary proteins, from animal origin, release an average of 68% of Nitrogen Catabolites; on the contrary (b) dietary proteins, from vegetable origin, release an average of 84% Nitrogen Catabolites; as well as (c), protein supplements from either vegetable or animal origin, release also an average of 84% Nitrogen Catabolites, because their protein sources are derived mainly from whey, casein or soy; on the other hand, (d) amino acid supplements containing less than eight essential amino acids (e.g. branched amino acids) release 100% Nitrogen Catabolites; meanwhile (e) amino acid supplements containing all eight essential amino acids (e.g. those derived from hydrolyzed proteins such as whey, casein or soy) release an average of 84% Nitrogen Catabolites. As a result, dietary proteins, protein or amino acid supplements can release approximately 68 to 99 times more metabolic toxic waste that must be catabilized through the liver and kidney functions, in comparison to the only one percent released by MAP Master Amino Acid Pattern®. These facts confirm why the use of MAP Master Amino Acid Pattern® is the safest in comparison to any dietary protein, protein or amino acid supplement, in order to avoid the overloading of both liver and kidney functions.


    Why does MAP Master Amino Acid Pattern® provide the lowest amount of calories, in comparison to any dietary protein, protein or amino acid supplement?

    Because scientific clinical studies results1-5,8-10 have shown that MAP Master Amino Acid Pattern®, after its absorption, provides only 0.04 kcal/g. By comparison, dietary proteins, protein or amino acid supplements provide 4 kcal/g. Namely, 99 times more calories than those provided by MAP Master Amino Acid Pattern®. Therefore, these facts confirm why MAP Master Amino Acid Pattern® provides the lowest amount in calories in comparison to any dietary protein, protein or amino acid supplement.


    And, why does MAP Master Amino Acid Pattern® provide a faster, lighter and easier digestion in comparison to any dietary protein, protein or amino acid supplement?

    Because scientific clinical studies results1-5,8-10 have shown that MAP Master Amino Acid Pattern®, is absorbed into the bloodstream through the small intestine within 23 minutes, after its oral ingestion.

    By comparison: (a) dietary proteins and protein supplements from either animal or vegetable origin, require a range of 3 to 6 hours to be digested; on the other hand, (b) amino acid supplements containing less than eight essential amino acids (e.g. branched amino acids) require a range of 2 to 3 hours; and (c) amino acid supplements containing all eight essential amino acids (e.g. those derived from hydrolyzed proteins such as whey, casein or soy, require also a range of 3 to 6 hours to be digested. As a result, dietary proteins, protein or amino acid supplements require a digestion time approximately 6 to 12 times longer than the one required by MAP Master Amino Acid Pattern®. Furthermore, as previously described, clinical studies have shown that 1 g (1 tablet) of MAP Master Amino Acid Pattern®, provides a Body Protein Synthesis (BPS) equivalent to 2.5 g of high biological value dietary proteins. This means that 10 tablets of MAP™ can provide at least the equivalent BPS of that provided by approximately 8 ounces (227 g) of cooked meat, fish or poultry. Therefore, these facts confirm why MAP Master Amino Acid Pattern® provides a faster, lighter and easier digestion in comparison to any dietary protein, protein or amino acid supplement.

    MAP Master Amino Acid Pattern®
    vs.
    Dietary Proteins & Protein Supplements

    CharacteristicsMAP Master Amino Acid Pattern®Dietary Proteins
    From Vegetable Origin
    Dietary Proteins
    From Animal Origin
    Protein Supplements
    From Either Animal or Vegetable Origin
    (e.g. such as whey, casein or soy)
    Amino Acid Supplements
    Not Containing the Eight Essential Amino Acids
    (e.g. branched amino acids)
    Amino Acid Supplements
    Containing All Eight Essential Amino Acids
    (e.g. proceeding from hydrolyzed proteins such as whey, casein or soy)
    NNU® for BPS99%16% (average)32% (average)16% (average)0%16% (average)
    Digestion Time23 minA range of
    3-6 hours
    (Approx. 6-12
    times longer)
    A range of
    3-6 hours
    (Approx. 6-12
    times longer)
    A range of
    3-6 hours
    (Approx. 6-12
    times longer)
    A range of
    2-3 hours
    (Approx. 4-6
    times longer)
    A range of
    3-6 hours
    (Approx. 6-12
    times longer)
    BPS/Time (NNU®/min)99% NNU®/ 23 min48-96
    times lower
    24-48
    times lower
    48-96
    times lower
    99
    times lower
    48-96
    times lower
    Released Nitrogen Catabolites1%84% (average)68% (average)84% (average)100% (average)84% (average)
    Energy0.04 kcal/g4 kcal/g4 kcal/g4 kcal/g4 kcal/g4 kcal/g
    Fecal residueAbsentPresentPresentPresentAbsentVariable
    ContraindicationsNoneRenal Failure or
    Hepatic Failure
    Renal Failure or
    Hepatic Failure
    Renal Failure or
    Hepatic Failure
    Renal Failure or
    Hepatic Failure
    Renal Failure or
    Hepatic Failure
    Adverse ReactionsNoneFood
    Sensitivities
    Food
    Sensitivities
    Food
    Sensitivities
    Food
    Sensitivities
    Food
    Sensitivities
    RefrigerationNot NeededNeededNeededNeededNot NeededVariable

    SCIENTIFIC REFERENCES RELATED TO MAP MASTER AMINO ACID PATTERN®


    1. Lucà-Moretti M. Comparative study of subjects’ Net Nitrogen Utilization (NNU) while receiving SON, a nutritional amino acid formula, or high biological value egg protein, or egg protein amino acid formula. JIMHA; 1:33-42, 1992.
    2. Lucà-Moretti M. Comparative study of subjects’ Net Nitrogen Utilization (NNU) while receiving SON, or egg protein or its protein amino acid formula. Advances in Therapy; 5:280-89, 1992.
    3. Lucà-Moretti M. Comparative study of subjects’ Net Nitrogen Utilization (NNU) while receiving bovine milk or soybean flour with or without SON nutrification. JIMHA; 1:43-54, 1992.
    4. Lucà-Moretti M. Comparative study of subjects’ Net Nitrogen Utilization (NNU) while receiving bovine milk or soybean flour with or without SON nutrification. Advances in Therapy; 5:290-301, 1992.
    5. Lucà-Moretti M., Grandi, A. The Malnutrition Treatment and Prevention Project. JIMHA; 2:20-26, 1993.
    6. Lucà-Moretti M., Grandi, A. Comparative Study of Subjects’ Weight Loss while receiving Very Low Calorie Diets consisting of SON, SON-Nutrified Dried Bovine Skim Milk, or Dried Bovine Skim milk provided in the required amounts to achieve Zero Nitrogen Balance. JIMHA; 2:39-48, 1993.
    7. Tamburlin N. L’importanza innovativa nell’uso del MAP per il controllo biologico del peso. La Medicina Biologica; 1:4-10, 1997.
    8. Lucà-Moretti M. Ensayo Comparativo sobre el MAP: el perfil ideal de aminoácidos esenciales para la nutrición humana, International Journal for Biomedical Research and Therapy; 4:9-14, 1997.
    9. Lucà-Moretti M. A Comparative, Double-blind, Triple Crossover Net Nitrogen Utilization Study Confirms the Discovery of the Master Amino Acid Pattern. Annals of the Royal National Academy of Medicine of Spain, Madrid; Vol. CXV: 397-416, 1998.
    10. Lucà-Moretti M. A Comparative, Double-blind, Triple Crossover Net Nitrogen Utilization Study Confirms the Discovery of the Master Amino Acid Pattern. Annals of the Royal Academy of Medicine of Zaragoza. Zaragoza; LXXII, 1998.
    11. Lucà-Moretti M. The International Nutrition Research Center Overweight Management Program. The Library of Congress, USA 1999.
    12. Fidone B. Rettocolite ulcerosa idiopatica: possibilita con MAP (SON Formula). La Medicina Biologica; 3:8-11, 1999.
    13. Sanseverino E. R. Vantaggi dell’utilizzo del MAP in eta’geriatrica. La Medicina Biologica; 3:17-19, 1999.
    14. Lucà-Moretti M. Programma di trattamento e prevenzione della malnutrizione. La Medicina Biologica; 3:35-38, 1999.
    15. Costanzo S. Nuova opportunita nella nutrizione delle popolazioni in situazioni di emergenza. La Medicina Biologica; 3:39-42, 1999.
    16. Mariani E., Vender G., Arrigotti E., Ferrario M., Rovelli E. Variazione di alcuni parametri antropometrici e fisiologici in una marciatrice cinquantenne prima e dopo l’attraversamento in solitaria del deserto cinese. La Medicina Biologica; 3:20-25, 1999.
    17. Tamburlin N. Trattamento ambulatoriale di pazienti con insufficienza renale cronica. La Medicina Biologica; 3:12-16, 1999.
    18. Muratori G. Sovrappeso e patologia articolare: SON Formula come terapia dimagrante ed antalgica un’ipotesi di lavoro. La Medicina Biologica; 17-20, 1999.
    19. Montilla C. Studio comparativo con e senza somministrazione di SON FORMULA® in soggetti affetti da anemia sideropenica sotto trattamento convenzionale. La Medicina Biologica; 3:2-7, 1999.
    20. Riccobene F. Impiego della neuralterapia sec. Huneke in casi di ritensione idrosalina non responsivi alla terapia diuretica in corso di dieta dimagrante con SON Formula. La Medicina Biologica; 3:48-52, 1999.
    21. Hermann G.F. Le intolleranze alimentari. La Medicina Biologica; 3:3-7, 2000.
    22. Corgna M. Pnei e patologie psiconutrizionali in omotossicologia. Il trattamento delle sindromi bulimiche. La Medicina Biologica; 3:8-16, 2000.
    23. Tamburlin N. Il SON Formula come opportunita nella gestione delle intolleranzealimentari. La Medicina Biologica; 3:24-29, 2000.
    24. Di Tullio G. Biotipologia del comportamento alimentare e utilizzo del SON Formula. La Medicina Biologica; 3:34-37, 2000.
    25. Ivaldi G.P. Esperienza nutrizionale in pazienti con insufficienza respiratoria. La Medicina Biologica; 3:49-54, 2000.
    26. Bufalini L. Nutrizione biologica integrata con SON Formula in pazienti affetti da sclerosi multipla. La Medicina Biologica; 3:55-61, 2000.
    27. D’Andrea G. Terapia delle obesitá: Studio comparativo di 10 casi clinici trattati con MAP (Son Formula™) e terapia omotossicologica versus Orlistat (Xenical 120mg Roche). La Medicina Biologica; 3:5-9, 2001.
    28. Di Tullio G. La Malattia asmatica: il ruolo della nutrizione biologica. La Medicina Biologica; 3:15-19, 2001.
    29. Del Prete M. Le malattie infiammatorie intestinali: importanza diagnostica e terapeutica del MAP. La Medicina Biologica; 3:20-26, 2001.
    30. Mariani M.M. Utilizzo del MAP (Master Amino acid Pattern) nel Programma “Quattro D” nell’insufficienza venosa cronica. La Medicina Biologica; 3:33-40, 2001.
    31. Falcone S., Cornoldi A., Brandetti F., Pili M., Badiali M., Spera G., Lubrano C. Integrazione con SON Formula in pazienti grandi obesi operati di by-pass biliointestinale presso il Policlinico Umberto I di Roma. La Medicina Biologica; 3:46-52, 2001.
    32. Fidone B. Nutrizione biologica integrata con SON Formula in pazienti affetti da insufficienza cardiaca. La Medicina Biologica; 3:53-66, 2001.
    33. Bufalini L. Rieducazione nutrizionale e terapia omotossicologica in pazienti anoressiche amenorroiche. La Medicina Biologica; 3:67-71, 2001.
    34. Polito A. Encefalopatia portosistemica in fase terminale in paziente cirrotico: Terapia con SON Formula. La Medicina Biologica; 49-50, 2001.
    35. Tamburlin N. Correlazioni tra micosi cutanuee ed intolleranze alimentari. La Medicina Biologica; 67-75, 2001.
    36. De Cristofano C., Giordano F. Terapia omeopatica integrata in un caso di cirrosi epatica scompensata. La Medicina Biologica; 51-52, 2002.
    37. Lucà-Moretti, M., Grandi A., Lucà E., Mariani E., Vender G., Arrigotti E., Ferrario M., Rovelli E. Comparative Results Between Two Groups of Track and Field Athletes with or without the use of Master Amino Acids Pattern® as protein substitute. Advances in Therapy; 4:195-202, 2003.
    38. Lucà-Moretti, M., Grandi A., Lucà E., Mariani E., Vender G., Arrigotti E., Ferrario M., Rovelli E Results of taking Master Amino Acids Pattern® as a sole and total substitute of dietary proteins in an athlete during a desert crossing. Advances in Therapy; 4:203-210, 2003.
    39. Lucà-Moretti, M., Grandi A., Lucà E., Muratori G., Nofroni M.G., Mucci M.P., Gambetta P., Stimolo R., Drago P., Giudice G., Tamburlin N., Karbalay M., Valente C., Moras G. Master Amino Acids Pattern® as sole and total substitute for dietary proteins during a weight loss diet to achieve the body’s Nitrogen Balance equilibrium. Advances in Therapy; 5:270-281, 2003.
    40. Lucà-Moretti, M., Grandi A., Lucà E., Muratori G., Nofroni M.G., Mucci M.P., Gambetta P., Stimolo R., Drago P., Giudice G., Tamburlin N. Master Amino Acids Pattern® as substitute for dietary proteins during a weight loss diet to achieve the body’s Nitrogen Balance equilibrium with essentially no calories. Advances in Therapy; 5:282-291, 2003.
    41. Ripa S. Il programma SON Formula. Argomenti di medicina estetica biologica; Guna Ed., Milano, 2004.
    42. Marucci S. Linfedema ereditario e malassorbimento proteico con deficit secondario di HGH. La Medicina Biologica; 21-25, 2004.
    43. Turco L. Rete ippocampale come modello della late-life: approccio farmacologico di regolazione nel senex. La Medicina Biologica; 55-59, 2004.
    44. Penco P., Frigerio F., Orlandi S., Molinari R. Progetto SET/K13: Rilievi su un caso estremo. La Medicina Biologica; 15-22, 2006.
    45. Lanza A. Intrauterine Growth Restriction prevention by Master Amino Acid Pattern. Atti del XXI Congresso Nazionale di Omeopatia, Omotossicologia e Medicina Biologica. La Medicina Biologica; 4:35-43, 2006.
    46. Ruggiero M., Ward E., Smith R., Branca J., Noakes D., Morucci G., Taubmann M., Thyer L., Pacini S. Oleic Acid, Deglycosylated Vitamin D-Binding Protein, Nitric Oxide: A molecular Triad Made Lethal to Cancer. Anticancer Research 34; 569-3578, 2014.